Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 2
1955 5
1956 3
1957 5
1958 6
1959 9
1960 5
1961 7
1962 7
1963 24
1964 21
1965 15
1966 24
1967 33
1968 25
1969 29
1970 18
1971 20
1972 29
1973 36
1974 40
1975 26
1976 28
1977 27
1978 19
1979 20
1980 19
1981 27
1982 14
1983 23
1984 14
1985 17
1986 14
1987 11
1988 10
1989 10
1990 4
1991 8
1992 17
1993 11
1994 10
1995 6
1996 19
1997 50
1998 57
1999 61
2000 45
2001 25
2002 26
2003 20
2004 10
2005 19
2006 24
2007 13
2008 12
2009 15
2010 25
2011 33
2012 47
2013 62
2014 63
2015 41
2016 49
2017 44
2018 42
2019 42
2020 43
2021 48
2022 62
2023 58
2024 69
2025 86
2026 65

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,870 results

Results by year

Filters applied: . Clear all
Page 1
Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
Lewis KH, Gudzune KA, Ard JD. Lewis KH, et al. Curr Obes Rep. 2024 Mar;13(1):132-140. doi: 10.1007/s13679-023-00546-9. Epub 2024 Jan 3. Curr Obes Rep. 2024. PMID: 38172485 Review.
RECENT FINDINGS: Recent research on phentermine is sparse and consists primarily of observational studies with methodologic limitations. ...There is no data to support the notion that phentermine is addictive. Although it remains the most commonly prescribed AOM in …
RECENT FINDINGS: Recent research on phentermine is sparse and consists primarily of observational studies with methodologic limitatio …
Obesity Pharmacotherapy.
Saunders KH, Umashanker D, Igel LI, Kumar RB, Aronne LJ. Saunders KH, et al. Med Clin North Am. 2018 Jan;102(1):135-148. doi: 10.1016/j.mcna.2017.08.010. Med Clin North Am. 2018. PMID: 29156182 Review.
The 6 most commonly used antiobesity medications are phentermine, orlistat, phentermine/topiramate extended release, lorcaserin, naltrexone sustained release (SR)/bupropion SR, and liraglutide 3.0 mg. ...
The 6 most commonly used antiobesity medications are phentermine, orlistat, phentermine/topiramate extended release, lorcaseri …
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Gadde KM, et al. Lancet. 2011 Apr 16;377(9774):1341-52. doi: 10.1016/S0140-6736(11)60205-5. Epub 2011 Apr 8. Lancet. 2011. PMID: 21481449 Clinical Trial.
FINDINGS: Of 2487 patients, 994 were assigned to placebo, 498 to phentermine 7.5 mg plus topiramate 46.0 mg, and 995 to phentermine 15.0 mg plus topiramate 92.0 mg; 979, 488, and 981 patients, respectively, were analysed. At 56 weeks, change in bodyweight was -1.4 k …
FINDINGS: Of 2487 patients, 994 were assigned to placebo, 498 to phentermine 7.5 mg plus topiramate 46.0 mg, and 995 to phentermin …
Diet pills redux.
Curfman GD. Curfman GD. N Engl J Med. 1997 Aug 28;337(9):629-30. doi: 10.1056/NEJM199708283370909. N Engl J Med. 1997. PMID: 9271487 No abstract available.
Phentermine/Topiramate: Pediatric First Approval.
Dhillon S. Dhillon S. Paediatr Drugs. 2022 Nov;24(6):715-720. doi: 10.1007/s40272-022-00532-z. Paediatr Drugs. 2022. PMID: 36059008 Review.
Phentermine/topiramate extended-release capsule (Qsymia( )) is a fixed-dose combination of phentermine and topiramate, which is being developed by VIVUS (a subsidiary of Icahn Enterprises) for the treatment of obesity, sleep apnoea syndrome, type 2 diabetes mellitus …
Phentermine/topiramate extended-release capsule (Qsymia( )) is a fixed-dose combination of phentermine and topiramate, which i …
Coronary Vasospasm Induced by Phentermine.
Franke KB, Psaltis PJ. Franke KB, et al. Mayo Clin Proc. 2019 Jul;94(7):1138-1140. doi: 10.1016/j.mayocp.2019.05.021. Mayo Clin Proc. 2019. PMID: 31272562 No abstract available.
Phentermine-Associated Pseudomembranous Colitis.
Gollol Raju NS, Jayananda S, Ali E, Harvin G. Gollol Raju NS, et al. Am J Ther. 2021 Jul-Aug 01;28(4):e492-e493. doi: 10.1097/MJT.0000000000001068. Am J Ther. 2021. PMID: 34228655 No abstract available.
Synthesis of Phentermine and its Derivatives.
Upadhyaya K, Shukla S, Meena BP, Dwivedi J. Upadhyaya K, et al. Curr Org Synth. 2024;21(5):583-594. doi: 10.2174/1570179420666230530095245. Curr Org Synth. 2024. PMID: 37259208 Review.
An amphetamine-like prescription drug called Phentermine (Adipex-P, Lomaira) is used to suppress appetite. In the last few years, Phentermine and its derivatives have attracted much attention due to their use in weight reduction; by reducing appetite or prolonging t …
An amphetamine-like prescription drug called Phentermine (Adipex-P, Lomaira) is used to suppress appetite. In the last few years, …
Cost-Effectiveness of Antiobesity Drugs for Adolescents With Severe Obesity.
Mital S, Nguyen HV. Mital S, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2336400. doi: 10.1001/jamanetworkopen.2023.36400. JAMA Netw Open. 2023. PMID: 37824146 Free PMC article.
While semaglutide offered more QALYs than phentermine-topiramate, its higher cost resulted in an incremental cost-effectiveness ratio ($1 079 480/QALY) that exceeded the commonly used willingness-to-pay threshold of $100 000 to $150 000/QALY. Orlistat and liraglutide cost …
While semaglutide offered more QALYs than phentermine-topiramate, its higher cost resulted in an incremental cost-effectiveness ratio …
Obesity.
Arterburn D. Arterburn D. Clin Evid. 2003 Dec;(10):676-89. Clin Evid. 2003. Update in: Clin Evid. 2004 Jun;(11):762-76. PMID: 15555115 Updated. Review. No abstract available.
1,870 results